OTC · TTOO
Healthcare · Medical - Diagnostics & Research
$0.00
Up+$0.00 (+16.67%)
Updated Oct 12, 2026, 9:59 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · TTOO
1M range · 0 trading sessions · Daily adjusted prices
TTOO does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning TTOO.
Company
Market Activity
Research & News
TTOO research
Company profile and research snapshot.
T2 BIOSYSTEMS INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2024 | Canaccord Genuity | Hold | — |
| Apr 29, 2024 | Canaccord Genuity | Hold | — |
| Jul 13, 2023 | Alliance Global Partners | Neutral | — |
| Jan 24, 2023 | Alliance Global Partners | Neutral | — |
| Oct 14, 2022 | Canaccord Genuity | Hold | — |
No generated briefing is available yet.
defenseworld.net · Dec 3, 2025
T2 Biosystems, Inc. (NASDAQ: TTOO - Get Free Report)'s share price crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $0.01 and traded as high as $0.0131. T2 Biosystems shares last traded at $0.0110, with a volume of 10,180 shares changing hands. T2 Biosystems
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TTOO.
No results
No recent SID articles mention TTOO.
